Minnesota enacted Senate File 3769, which restricts the delivery of 340B prescription drugs by third parties. The bill, passed by the Senate on April 7, 2026, modifies how covered entities (hospitals, federally qualified health centers, and other safety-net providers) participating in the federal 340B drug pricing program can receive discounted medications. The legislation addresses concerns about contract pharmacy arrangements and mail-order delivery of 340B drugs.

Healthcare providers and covered entities in Minnesota that participate in the 340B program must review their current drug delivery arrangements and ensure compliance with the new restrictions. Pharmaceutical manufacturers and contract pharmacy partners should also assess the operational impact on 340B drug distribution within the state. The law represents a significant state-level intervention in federal 340B program operations.